Pos0733 Validation Of The Sle-Das Responder Index As An Accurate And Feasible Endpoint For Sle Clinical Trials: A Post-Hoc Study In The Phase 2 And 3 Anifrolumab Clinical Trials

AuthID
 P-01A-QEW
5
Author(s)
Jesus, D
·
Matos, A
·
Doria, A
·
Inês, L
Document Type
Article
Year published
2024
Published
in Annals of the Rheumatic Diseases, ISSN: 0003-4967
Volume: 83, Pages: 1004-1005
Indexing
Crossref®
Google Scholar®
Publication Identifiers
Source Identifiers
ISSN: 0003-4967
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service